David Shaw’s DA32 Life Science Tech Acquisition Corp. Class A Common Stock DALS Stock Holding History

David Shaw’s Portfolio DALS Stock Details DALS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-45,992	Closed	-$472K	–	4655
2023 Q2	$472K	Hold	45,992	–	–	﹤0.01%	3447
2023 Q1	$465K	Hold	45,992	–	–	﹤0.01%	3583
2022 Q4	$460K	Hold	45,992	–	–	﹤0.01%	3897
2022 Q3	$446K	Hold	45,992	–	–	﹤0.01%	4111
2022 Q2	$446K	Hold	45,992	–	–	﹤0.01%	4161
2022 Q1	$448K	Buy	45,992 +2,300	+5%	+$22.2K	﹤0.01%	4438
2021 Q4	$429K	Buy	43,692 +23,916	+121%	+$234K	﹤0.01%	4490
2021 Q3	$194K	Buy	+19,776	New	+$195K	﹤0.01%	4576

David Shaw's DALS Position: Q3 2023 in Review

David Shaw sold out of DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) in Q3 2023, closing a stake of 45,992 shares — an estimated $472K sold.

David Shaw first reported a position in DALS in Q3 2021 and held it in 8 quarters. The position peaked at $472K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

David Shaw reported no remaining DA32 Life Science Tech Acquisition Corp. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
David Shaw sold 45,992 DA32 Life Science Tech Acquisition Corp. Class A Common Stock shares in Q3 2023, an estimated $472K.
David Shaw first reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in Q3 2021 and held it in 8 quarters.
David Shaw's DA32 Life Science Tech Acquisition Corp. Class A Common Stock position peaked at $472K in Q2 2023.
0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp. Class A Common Stock as of Q3 2023.

Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.